Philip Lee is an internationally recognised firm in the pharmaceutical and life science sectors.

Our clients choose us for our detailed technical knowledge and our breadth and depth of experience across all areas of law and policy that affect business in these sectors.

We work with globally acclaimed medical technology companies as well as multinational pharmaceutical companies, and are proud of our work with start-up and early stage companies too.

We have developed invaluable relationships with key stakeholders in the Irish healthcare system. The firm is an affiliate member of the Irish Pharmaceutical Healthcare Association (IPHA) and is a member of the Irish Business and Employers Confederation (Ibec) which includes a specialist group concentrating on the medical devices and med tech sectors.

We advise many of the world’s leading pharmaceutical companies on all aspects of their operations in Ireland, including in relation to clinical research, clinical trial arrangements, licensing and other pharmaceutical-regulatory issues, dealings with the Healthcare Products Regulatory Authority, distribution arrangements, market access, competition law issues, outsourced service arrangements, sponsorship and funding issues, pricing and reimbursement, public sector procurement of medicines, and in relation to advertising and marketing activities.

Members of our team also have in-depth experience in advising global and domestic players in the pharma sector on M&A, corporate transactional and equity (including IPOs) and debt fundraisings, including on the use of Ireland as a platform for multi-lateral activities.

Our intellectual property team frequently advises our pharmaceutical clients on issues such as patent infringement, patent life cycles, data and marketing exclusivity issues, trade mark infringement via parallel importation and copyright issues.

Our team members are experts in data protection and privacy, which are important issues for our pharmaceutical sector clients.

As with our other core areas, we work to ensure that we have the expertise and market knowledge to exceed our clients’ expectations.

We advise a large number of leading international medical device companies as well as many early stage and developing companies in this sector.

Our work is wide-ranging, and includes advising our clients on their research arrangements, clinical investigations, licensing and regulatory requirements (including in relation to obtaining CE marking), technology licensing issues, data protection and privacy issues (including in relation to patient consent), distribution arrangements, market access and in relation to advertising and marketing.